April 25, 2012 12:48 PM | 1 min read
20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
Credit Suisse assumes its Outperform rating on Vivus (NASDAQ: VVUS) and lowers its price target from $36 to 34. Credit Suisse notes, "If approved, Qnexa is certain to carry a risk management program ("REMS"); the impact of this on Qnexa's revenues is uncertain. We suspect the REMS may impact both the launch trajectory and peak - we are cutting our US revenue forecasts through 2020. Other changes to our model include: assuming 100% of EU revenues (vs. only a 20% royalty previously) and higher SG&A in 2014 and beyond as VVUS scales up a large GP field force after the initial launch. These changes are outlined in Exhibits 1-2. The net result is our target price goes to $34 (from $36)."CP closed at $22.43 on Monday.
20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.